Solomon H. Snyder

Solomon Snyder was born on December 26, 1938 in Washington D.C. He is one of five children.[2] Snyder and his wife Elaine, who died in 2015, have two daughters and three grandchildren. He lives in Baltimore, Maryland.

Snyder attended Georgetown University from 1955 to 1958 and received his M.D. degree from Georgetown University School of Medicine in 1962. After a medical residency at the Kaiser Hospital in San Francisco, he served as a research associate from 1963 to 1965 at the National Institutes of Health, where he studied under Julius Axelrod. Snyder moved to the Johns Hopkins University School of Medicine to complete his residency in psychiatry from 1965 to 1968. He was appointed to the faculty there in 1966 as Assistant Professor of Pharmacology. In 1968 he was promoted to Associate Professor of Pharmacology and Psychiatry and in 1970 to Full Professor in both departments.

His laboratory is noted for the use of receptor binding studies to characterize the actions of neurotransmitters and psychoactive drugs.

He is also known for his work identifying receptors for the major neurotransmitters in the brain, and in the process explaining the actions of psychoactive drugs, such as the blockade of dopamine receptors by antipsychotic medications. He has described novel neurotransmitters, such as the gases nitric oxide and carbon monoxide and the D-isomers of amino acids, including D-serine.

Snyder is University Distinguished Service Professor of Neuroscience, Pharmacology, and Psychiatry at the Johns Hopkins University School of Medicine. In 1980, he founded the Department of Neuroscience, and served as its first director from 1980 to 2006. In 2006, the department was renamed as The Solomon H. Snyder Department of Neuroscience in his honor. Snyder is also the Director of Drug Discovery at the Lieber Institute for Brain Development in Baltimore, MD.[4]

In 1980, he served as the President of the Society for Neuroscience. He is also Associate Editor, Proceedings of the National Academy of Sciences of the United States of America. He helped start the companies Nova Pharmaceuticals and Guilford Pharmaceuticals, and has been an active philanthropist.

He is listed by the Institute for Scientific Information as one of the 10 most-often cited biologists and he also has the highest h-index of any living biologist.